Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H18FN7 |
Molecular Weight | 351.3808 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC1=C(CN2C=CN=C2C3=NC=CC=C3F)N=CN4N=C(C)N=C14
InChI
InChIKey=UAMAIHOEGLEXSV-UHFFFAOYSA-N
InChI=1S/C18H18FN7/c1-3-5-13-15(22-11-26-17(13)23-12(2)24-26)10-25-9-8-21-18(25)16-14(19)6-4-7-20-16/h4,6-9,11H,3,5,10H2,1-2H3
Molecular Formula | C18H18FN7 |
Molecular Weight | 351.3808 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Adipiplon is an oral, partial agonist of the GABAA alpha-3 (α3) receptor that was being developed by Neurogen Corporation for the treatment of insomnia, anxiety disorders and schizophrenia. Adipiplon has been tested in Phase 1 and 2 studies in over 600 subjects for the treatment of insomnia, demonstrating statistical significance compared to placebo on primary endpoints for sleep initiation and maintenance in patients with chronic insomnia. Adipiplon has also demonstrated statistical significance compared to placebo for self-reported quality of sleep in all completed Phase 2 studies to date. Additionally, in studies completed to date it has been well tolerated at all doses tested. Development of adipiplon was discontinued during 2008.
Originator
Approval Year
Sample Use Guides
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:50:08 GMT 2023
by
admin
on
Fri Dec 15 15:50:08 GMT 2023
|
Record UNII |
OPL214POJ1
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2103791
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
C76933
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
SS-66
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
DTXSID40232944
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
OPL214POJ1
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
300000034122
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
8858
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
ADIPIPLON
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
11198924
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
840486-93-3
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY | |||
|
DB06579
Created by
admin on Fri Dec 15 15:50:08 GMT 2023 , Edited by admin on Fri Dec 15 15:50:08 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->PARTIAL AGONIST |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|